Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF
- 24 February 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 335 (8687), 434-437
- https://doi.org/10.1016/0140-6736(90)90665-r
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Stimulation of Myelopoiesis in Patients with Aplastic Anemia by Recombinant Human Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1988
- Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassayBlood, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primatesBlood, 1987
- Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.Proceedings of the National Academy of Sciences of the United States of America, 1985
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant ProteinsScience, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970